Coherus BioSciences, Inc. markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor.Pipeline products include biosimilars of Humira, Avastin, and Lucentis. Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China.
